AIREX (Acute Infarction Ramipril Evaluation Extension Study)

AIREX (Acute Infarction Ramipril Evaluation Extension Study)

18 Mar, 14

Listen

Stop

Study Patients

603 patients involved in AIRE

Study Treatment

Ramipril 5 mg/day vs Placebo

Mean Follow-up Period

59 months

Results

All-cause mortality was reduced by 36% with ramipril vs placebo

Conclusion

Survival benefits with ramipril were sustained over many years in patients with HF post MI

Lancet 1997;349:1493-7

Related Topics